Project Coordinator Prof. Kenny has won the Enterprise Ireland Life Sciences & Food Commercialisation Award for developing and commercialising the first predictive diagnosis for pre-eclampsia in early pregnancy. Professor Kenny received the award at the Enterprise Ireland Big Ideas Technology Showcase which took place in Dublin on 25 September 2013. Presenting Professor Kenny with her … Read more
IMPROvED has attained membership of the European Society for Biopreservation and Biobanking (ESBB). The ESBB is a society for people involved in the collection and storage of biological materials from all species. The society, a regional chapter of the ISBER (International Society for Biological and Environmental Repositories), is focussed on Europe, the Middle East and … Read more
The study is publically available at ClinicalTrials.gov as of June 27, 2013 (identifier NCT 01891240). Go to the study record details. ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. ClinicalTrials is a service of the U.S. National Institutes of Health.
The Directorate-General for Research and Innovation of the EC has issued a publication focussing on a group of diseases that are called ‘rare’ but actually affect over 30 million Europeans. IMPROvED is featured as one of the projects under “Cardiovascular, pulmonological and haematological disorders” on page 35 of this interesting and informative booklet. This section contains … Read more
IMPROvED project coordinator Prof. Louise Kenny (University College Cork), is to hold a presentation at the the next European ISSHP Congress in Tromsø, Norway, June 2013. The congress will provide a great opportunity to introduce the study the worldwide scientific community. The international Society for the Study of Hypertension in Pregnancy (ISSHP), founded in 1976, aims to … Read more
IMPROvED outlook for pre-eclampsia due to €6M EU award. A consortium led by University College Cork (UCC) has secured €6 million euro in FP7-health framework research funding to combat pre-eclampsia, a life-threatening pregnancy complication. The condition, whereby high blood pressure arises in the second half of pregnancy, accounts for as much as 24% of maternal … Read more